Deals review
- Deals review
- Deal details
European collaboration agreement in dermatology
In order to access this content you must be logged in and have a subscription to Pharmalicensing Intelligence.
Pharmalicensing Intelligence is a one-stop environment for time-conscious executives. Keeping you abreast of the latest developments in the life sciences industry, saving you time and money when you need it most.
Related deals
NicOx and Ferrer expand collaboration in dermatology
GSK Consumer Healthcare gains Rx dermatology products
NicOx and Ferrer select candidate for development in dermatology collaboration
Bayer Acquires Two Prescription Dermatology Product Lines from SkinMedica in the U.S.
Barrier Therapeutics Establishes European Commercialization Agreement Covering Four Products
Commercial Collaboration Agreement
Berlex to enter dermatology market
ACRUX SIGNS COMMERCIAL DEAL WITH NAPA BIOSCIENCES FOR DERMATOLOGY PRODUCTS
Related categories
- Therapeutic target
- Infectious diseases
More deals
Latest deals
- Biovator and BASF sign technology development agreement
- Agfa HealthCare signs four-year agreement with Chinese partners for distribution of radiography solutions, potentially worth 500 million US dollar
- Omnicare Announces Acquisition of Continuing Care Rx
- Nabi Biopharmaceuticals Announces Long-Term Manufacturing Agreement With Diosynth RTP
- GreenVax Selects Xcellerex XDR Single-Use Bioreactors for New Vaccine and Biotherapeutics Program
Most viewed deals
- Recommended acquisition of Acambis plc ("Acambis") by Sanofi Pasteur Holding ("Sanofi Pasteur") by way of scheme of arrangement Posting of Scheme Document
- Omnicare Announces Acquisition of Continuing Care Rx
- Bayer CropScience and Janssen PMP conclude research agreement:
- Nabi Biopharmaceuticals Announces Long-Term Manufacturing Agreement With Diosynth RTP
- Biovator and BASF sign technology development agreement
© Copyright 1998-2013 IP Technology Exchange, Inc All rights reserved. Terms and Conditions | Contact us